Global Lacrimal Cannulae Market Size By Type (Straight Lacrimal Cannulae, Curved Lacrimal Cannulae), By Application (Eye Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Lacrimal Cannulae Market was valued at USD 112.4 million in 2023 and is projected to reach USD 187.9 million by 2031, expanding at a CAGR of 6.5% during the forecast period of 2023–2031. The growth of the lacrimal cannulae market is primarily driven by increasing cases of eye disorders, the rising geriatric population, advancements in ophthalmic surgical tools, and the surge in demand for minimally invasive procedures. Lacrimal cannulae play a crucial role in procedures involving tear duct irrigation, drug delivery, and probing, especially in treating nasolacrimal duct obstruction and other lacrimal system diseases.

Drivers:

1. Rising Incidence of Ocular Disorders:

Conditions like dry eye syndrome, dacryocystitis, and congenital nasolacrimal duct obstruction are becoming more prevalent, particularly in aging populations. This is fueling the demand for lacrimal cannulae for both diagnostic and therapeutic procedures.

2. Technological Advancements in Ophthalmology:

Innovations in cannula design—including curved tips, flexible shafts, and atraumatic features—are enhancing procedural efficacy and patient comfort, contributing to increased adoption across healthcare settings.

3. Growing Demand for Minimally Invasive Procedures:

Minimally invasive lacrimal surgeries are becoming the standard of care due to reduced recovery time and complication risks, encouraging ophthalmic surgeons to use lacrimal cannulae more frequently.

Restraints:

1. Limited Reimbursement in Emerging Markets:

Lack of robust insurance coverage for ophthalmic surgeries and diagnostic interventions in developing countries hampers the adoption of advanced lacrimal cannulae.

2. Availability of Alternatives:

Alternative tools and procedures like balloon catheter dilation or endoscopic surgeries may limit the usage of traditional lacrimal cannulae in certain cases, restricting market growth.

Opportunity:

1. Expanding Geriatric Population Globally:

As the global elderly population grows, so does the incidence of age-related eye disorders, which require frequent irrigation and probing—presenting lucrative opportunities for manufacturers.

2. Increasing Investment in Eye Care Infrastructure:

Healthcare providers and governments are enhancing ophthalmic care infrastructure, particularly in Asia-Pacific and Latin America, opening new avenues for market expansion.

3. Surge in Pediatric Eye Care:

Rising awareness and early diagnosis of congenital eye disorders are increasing the usage of lacrimal cannulae in pediatric ophthalmology.

Market by System Type Insights:

Based on system type, straight lacrimal cannulae held the dominant share in 2023 due to their wide application in both irrigation and intubation procedures. However, the curved lacrimal cannulae segment is projected to grow at a higher rate due to their improved anatomical adaptability, especially in complex or pediatric procedures where precise navigation of the lacrimal duct is critical.

Market by End-use Insights:

In terms of end-use, hospitals and specialty clinics accounted for the largest market share in 2023. This is attributed to the rising number of outpatient and in-clinic ophthalmic procedures. Meanwhile, ambulatory surgical centers (ASCs) are expected to witness rapid growth due to increasing preference for same-day surgeries and cost-effective treatment options.

Market by Regional Insights:

North America led the global lacrimal cannulae market in 2023, driven by high healthcare expenditure, advanced ophthalmic practices, and the presence of key market players. Asia-Pacific is expected to be the fastest-growing region over the forecast period due to rising awareness, improving healthcare access, and an expanding elderly population base in countries such as China, India, and Japan. Europe also holds a significant share, supported by well-established healthcare infrastructure and a growing number of ophthalmic surgeries.

Competitive Scenario:

Key players in the Global Lacrimal Cannulae Market include BVI Medical (Beaver-Visitec International), Rumex International, Accutome (a Halma company), Karl Storz SE & Co. KG, and Medtronic plc. These companies are focusing on product innovation, geographic expansion, and strategic collaborations to enhance their global presence. For example:

In 2023, Rumex International introduced an ergonomically enhanced lacrimal cannula with improved flow dynamics for precise irrigation procedures.

BVI Medical launched a new pediatric-friendly lacrimal cannula line in 2024, tailored for congenital nasolacrimal duct obstruction management.

Scope of Work – Global Lacrimal Cannulae Market

Report Metric Details

Market Size (2023) USD 112.4 million

Projected Market Size (2031) USD 187.9 million

CAGR (2023–2031) 6.5%

Key Segments System Type (Straight, Curved), End-use (Hospitals & Clinics, ASCs), Region

Growth Drivers Rising incidence of ocular disorders, technological advancements, growing demand for minimally invasive procedures

Opportunities Geriatric care expansion, pediatric applications, healthcare investments in emerging regions

Key Market Developments:

2023: BVI Medical unveiled a precision-tip lacrimal cannula with enhanced flow control for safer ophthalmic procedures.

2024: Karl Storz announced a partnership with academic hospitals in Europe to integrate their lacrimal surgery tools in medical training programs.

2025: Accutome expanded its manufacturing facility in the U.S. to increase production capacity for ophthalmic surgical instruments, including lacrimal cannulae.

FAQs:

1. What is the current market size of the Global Lacrimal Cannulae Market?

The market was valued at USD 112.4 million in 2023.

2. What is the major growth driver of the Global Lacrimal Cannulae Market?

The rising prevalence of eye disorders and increasing adoption of minimally invasive surgical procedures are major growth drivers.

3. Which is the largest region during the forecast period in the Global Lacrimal Cannulae Market?

North America is projected to retain the largest market share during the forecast period.

4. Which segment accounted for the largest market share in the Global Lacrimal Cannulae Market?

Straight lacrimal cannulae accounted for the largest share in 2023 due to their versatility in various eye procedures.

5. Who are the key market players in the Global Lacrimal Cannulae Market?

Key players include BVI Medical, Rumex International, Accutome, Karl Storz SE & Co. KG, and Medtronic plc.